Related Experiment Video
Updated: Mar 8, 2026

11:04
Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
Published on: June 23, 2018
7.7K
Protein aggregation, misfolding and consequential human neurodegenerative diseases.
Neha Sami1, Safikur Rahman2, Vijay Kumar1
1a Centre for Interdisciplinary Research in Basic Sciences , Jamia Millia Islamia , New Delhi , India.
The International Journal of Neuroscience
|January 24, 2017
Summary
Protein misfolding causes neurodegenerative diseases like Alzheimer's and Parkinson's. Molecular chaperones prevent this, offering potential for early diagnosis and treatment strategies.
Area of Science:
- Molecular biology
- Neuroscience
- Biochemistry
Background:
- Proteins must achieve a stable 3D structure for cellular function.
- Misfolded proteins can aggregate, leading to cellular dysfunction and tissue damage.
- Protein misfolding is implicated in neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and ALS.
Purpose of the Study:
- To review human neurodegenerative diseases caused by protein misfolding.
- To highlight the pathomechanisms underlying these diseases.
- To discuss potential therapeutic interventions.
Main Methods:
- Literature review of scientific articles on protein misfolding and neurodegeneration.
- Analysis of pathomechanisms involved in protein conformational disorders.
- Exploration of current and potential therapeutic strategies.
Main Results:
- Protein misfolding and aggregation are central to the pathogenesis of major neurodegenerative disorders.
- Innate molecular chaperones play a crucial role in preventing protein misfolding.
- Understanding these processes is key to developing diagnostic and therapeutic approaches.
Conclusions:
- Targeting protein misfolding pathways presents a promising avenue for treating neurodegenerative diseases.
- Further research into molecular chaperones and therapeutic interventions is warranted.
- Early diagnosis and efficient management strategies can be developed based on this knowledge.
Related Concept Videos
Amyloid Fibrils
12.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.4K
Amyloid Fibrils
6.8K
6.8K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Proteins: From Genes to Degradation
14.8K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.8K

